Global Smoking Cessation and Nicotine De-Addiction Products Market to Be Worth US$20.8 Bn by 2023

Transparency Market Research Report Added "Smoking Cessation and Nicotine De-addiction Products Market" to its database.

Logo

Albany, NY -- (SBWire) -- 01/19/2016 --Transparency Market Research has published a new market report titled, "Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023." According to the report, global smoking cessation and nicotine de-addiction products market was valued at US$ 6.5 Bn in 2014 and is anticipated to expand at a CAGR of 13.7% from 2015 to 2023 to reach US$ 20.5 Bn by 2023.

Browse the full Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/smoking-cessation-nicotine-de-addiction-products.html

The report provides detailed analysis of current and emerging market trends associated with for global smoking cessation and nicotine de-addiction products market, bifurcating them based on type of products. Cigarette smoking is a chronic problem across the globe. There is increased focus on adverse economic and health impact of smoking. Tobacco contains nicotine which is addictive, and thus, tobacco smoking may lead to nicotine addiction. Smoking cessation aids mainly include nicotine replacement therapy (NRT) products and drugs which may be coupled with counselling and psychotherapy. However, certain nicotine withdrawal symptoms are observed during the process of smoking cessation which include anxiety and irritability, due to which the person may again start smoking.

The first line treatment for smoking cessation comprises either nicotine replacement therapy (NRT) products or drug therapy. However, recently people willing to quit smoking are also seen preferring e-cigarettes instead of NRT and drugs. E-cigarettes provide smokers with the same feeling as that with cigarettes, however are known to assist in lowering nicotine addiction, though there has been a lot of debate about categorization of e-cigarette as a smoking cessation aid. The major setback is expected to affect the global smoking cessation and nicotine de-addiction products market due to loss of patent exclusivity of the most recognized brand Zyban (bupropion) during the forecast period in the year 2013, and to a certain extent due to Chantix/Champix (varenicline) at the end of the forecast period. The market for smoking cessation and nicotine de-addiction products has been categorized on the basis of prominently used product types: nicotine replacement therapy (NRT), drug therapy and e-cigarettes. The NRT segment includes nicotine containing gums, patches, lozenges, sublingual tablets, inhalers and mouth sprays, of which, gums, patches and lozenges contribute to maximum revenue. The e-cigarette segment will exhibit fastest growth and thus, is expected to boost the global smoking cessation and nicotine de-addiction products market. E-cigarettes have proved to be a better alternative to cigarettes whose smoke contains various harmful gases and cause dreadful diseases such as cancer. However, many countries from regions such as Southeast Asia, and Europe have banned the sales of E-cigarettes.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1849

The market for NRT products is consolidated with the top players capturing over major share with key players such as Johnson & Johnson, GSK, and Pfizer. The drug therapy market is dominated by GSK and Pfizer. The key players in the e-cigarette market include NJOY, VMR Products LLC, Lorillard, Inc., and Nicotek LLC.

The global smoking cessation and nicotine de-addiction products market has been segmented as follows:

Smoking Cessation and Nicotine De-Addiction Products Market, by Type
Nicotine Replacement Therapy Products
Nicotine Gums
Nicotine Transdermal Patches
Nicotine Lozenges
Nicotine Sprays
Nicotine Inhalers
Nicotine Sublingual Tablets
Drug Therapy
Zyban (bupropion)
Chantix/Champix (varenicline)
E-cigarettes
Smoking Cessation and Nicotine De-Addiction Products Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
India
China
Rest of Asia Pacific
Rest of the World (RoW)
Latin America (LATAM)
Middle East and North Africa (MENA)

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Media Relations Contact

Mr. Sudip S
Assistant Manager
Transparency Market Research
518-618-1030
http://www.transparencymarketresearch.com/pressrelease/smoking-cessation-nicotine-de-addiction-products.htm

View this press release online at: http://rwire.com/657018